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ABSTRACT OF DISSERTATION 
 
 
INVESTIGATION OF THE BIOSYNTHESIS OF THE NUCLEOSIDE ANTIBIOTIC 
SPHAERIMICIN 
 
Antibiotic-resistance has become a widespread problem in the United States and 
across the globe. Meanwhile, new antibiotics are entering the clinic at an alarmingly low 
rate. Highly-modified nucleosides, a class of natural products often produced by 
actinobacteria, target MraY bacterial translocase I. MraY is a clinically unexploited 
enzyme target that is ubiquitous and essential to peptidoglycan cell wall biosynthesis. The 
nucleoside antibiotics known vary in efficacy and the functionalities contributing to 
improved activity is poorly understood. Sphaerimicin, a newly discovered modified 
nucleoside, has potent inhibitory activity with an IC50 of 13.65 nM against MraY. In 
general, sphaerimicin is primarily effective against gram-positive bacteria (MIC ranges 
from 2-16 μg/mL against Enterococcus faecium and Staphylococcus aureus), but little is 
known about the biosynthesis and mechanism of action. Sphaerimicin has highly unusual 
structural features, including a heavily modified ribosylated glycl-uridine disaccharide core 
that is appended to a dihydroxylated piperidine ring. 
 
The novel biosynthesis of these features was investigated, leading to the functional 
characterization of six enzymes critical for the disaccharide core formation from uridine 
monophosphate. Recently, a unique S-adenosylmethionine- and PLP-dependent alpha-
aminobutyric acid transferase and a nonheme Fe(II)- and alpha-ketogluterate-dependent 
hydroxylase from the sphaerimicin biosynthetic pathway were characterized. This part of 
the pathway extends the carbon scaffold, which will be crucial for formation of the 
piperidine ring. Not only does this study provide new chemical entities to help better 
understand MraY as a target, it could potentially reveal new enzymatic chemistries that 
will power innovative chemoenzymatic synthesis and genome mining to uncover new 
natural products. 
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 RELEVANCY OF STUDYING BIOSYNTHESIS OF HIGHLY-MODIFIED 
NUCLEOSIDE ANTIBIOTICS 
1.1 Antibiotic resistance 
Antibiotic resistance has become a widespread problem in the United States and 
across the globe. Out of billions of bacterial cells, some evolve through random mutation 
to have drug-resistance. Antimicrobial drugs have been susceptible to antibiotic resistance 
since they were first used to treat infections; penicillin resistance was identified the same 
decade it was introduced. This antibiotic resistance threat has long been known and was 
predicted by Alexander Fleming in the 1940’s before resistance had even developed [1-3]. 
Selective pressure of antibiotics on microorganisms accelerates this environmental 
resistance, as the bacteria that survive the antibiotic treatment are now more likely to have 
and share a form of drug-resistance with other bacteria [4]. This can have ripple effects, 
impacting both the individual and the community. Allergic reactions, disruption of gut 
microbiota, and increased incidence of drug-resistance are all adverse effects of this 
selective pressure [2]. Just a few of the most serious resistance stains, according to the 
CDC, includes carbapenem-resistant Enterobacteriacae, extended spectrum β-lactamase 
producing Enterobacteriacae, vacomycin-resistant Enterobacteriacae, and methicillin-
resistant Staphylococcus aureus [2]. 
This is a multifaceted problem and an interdisciplinary team is needed to answer it 
from multiple angles. Treating and preventing a drug-resistance crisis involves four major 
areas of focus. This includes improved prescribing/stewardship from physicians, tracking 
big data by biostatisticians, preventing infections through public health awareness, and 
2 
 
developing new drugs from the benchtop and translating that into successful clinical trials 
[2]. Vancomycin, which took three decades to develop resistance, proved to be an excellent 
example of how carefully prescribing an effective drug only when necessary could keep 
remaining “last-resort” drugs effective for decades. 
1.2 Natural product biosynthesis 
New antibiotics are desperately needed. Penicillin sparked interest in natural 
product drug discover, leading to a “discovery golden age” of biosynthetically-derived 
therapeutics from the 1940-50’s. Although organizations like the CDC and WHO promote 
the advance of new antibiotics, little clinical progress has been made in the last few 
decades. Apart from daptomycin, a lipopeptide discovered in the late 1980’s, there have 
been little-to-no new classes of antibiotics entering the clinic since 1981, creating a 
discovery void (Error! Reference source not found.) [3]. CDC data suggests this has had 
a detrimental impact: an increase in death and illness originating from antibiotic-resistance 
(estimates of over two million illnesses and 23 thousand deaths) [2]. 
 
Figure 1.1 Adapted representation of WHO data on number of new classes of antibiotics 




The development of new antimicrobial drugs using natural products (i.e. 
compounds derived from secondary metabolism in a variety of organisms) is a promising 
route [5]. Natural products (NPs) or semi-synthetic derivatives of NPs are known to vary 
greatly in molecular weight, number of rings, ring systems, heteroatoms, rotatable bonds, 
stereocenters, and hydrophilicity [6, 7]. Approximately half of all new drug approvals have 
originated from NPs, likely due to their rich chemical diversity [5, 6]. This large and unique 
region of underexplored chemical space compared to synthetic origins has fueled NP-based 
drug discovery [6]. Additionally, the machinery orchestrating these biosynthetic 
transformations often offer new chemistries not visible by traditional synthetic means [8]. 
1.3 MraY bacterial translocase I 
Antibacterial activity can occur through several mechanisms such as the inhibition 
of nucleic acid metabolism and repair, protein synthesis, folate synthesis, and enzymes 
involved in cell wall biosynthesis [9, 10]. With little overlap between cell wall biosynthesis 
in prokaryotic cells and any cellular activity in eukaryotic cells, cytotoxicity is less likely 
to occur in mammalian cells when inhibiting this pathway. Further, inhibition of 
peptidoglycan cell wall biosynthesis is only partially explored as just six of twelve minimal 
enzymatic steps have known targets [11-13]. MraY bacterial translocase I is currently an 
unexploited target in the clinic. MraY catalyzes the second stage of cell wall biosynthesis, 
transferring a phosphor-N-acetylmuramyl pentapeptide from uridine monophosphate to a 
C55 undecaprenyl phosphate (C55-P) held in the lipid membrane to create undecaprenyl-
pyrophosphoryl-MurNAc-pentapeptide (lipid I, see Error! Reference source not found.) 
[9, 14-18]. This will go on to be an integral part of the peptidoglycan cell wall. 
Additionally, eukaryotic cytotoxicity is less of a concern, as similar proteins in eukaryotic 
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cells share very little sequence similarity to MraY. This is a proven pathway to target: 
transglycosylase inhibitors (e.g. vancomycin) and transpeptidase inhibitors (e.g. β-lactams) 
are widely used in the clinic. Tunicamycin, a well-known nucleoside antibiotic, can inhibit 
this step of biosynthesis; however, tunicamycin displays prominent cytotoxicity with 
inhibitory activity against dolichyl phosphate:N-acetylglucosamine-1-phosphate 
transferase [9, 19]. This enzyme catalyzes a similar reaction to MraY in eukaryotic cells. 
Interestingly, MraY is ubiquitous and essential across gram-positive and gram-negative 
bacteria. Considering this, MraY is a promising target in combating antibiotic resistance. 
 
Only a few crystal structures of MraY have been resolved since its discovery in the 
1990’s, so current structural insight into MraY is minimal. There are significant differences 
between the MraY native substrates and known inhibitors. Many inhibitors lack the 
diphosphate found in the natural substrate (UDP-MurNAc-pentapeptide), instead baring an 
extra modified ribosyl unit. One recent study of muraymycin D2 binding MraY supported 
that a large conformational change may accommodate these major differences. 
Figure 1.2 Partial illustration of cell wall biosynthesis noting how MraY fits into the 
overall pathway. Also noted are a selection of current antibiotics used to clinically to treat 




Muraymycin D2 does not interact with three acidic residues, nor the magnesium cofactor, 
essential to native substrate binding [20-22]. The functionalities of these inhibitors that 
strengthen or weaken enzyme-inhibitor interaction are poorly understood. The work 
described throughout this thesis should provide tools to further inform structure-activity 
relationships of this interaction, getting closer to the answer of what makes an MraY 
inhibitor efficacious. 
1.4 GlyU-ADR nucleoside antibiotics 
A subset of MraY inhibitors include nucleoside antibiotics with a GlyU-ADR core 
derived from UMP [14-16, 23]. Examples of this subset includes FR-900493, 
muraminomicins, muramycins, liposidomycins, caprazamycins, sphaerimicins, and A-
90289 (Figure 1.3) [14-18, 23-25]. New members of this subset are still being discovered, 
for example Cui et al discovered three new muraymycins most recently [26]. The GlyU-
ADR-containing nucleosides have thus far displayed no cytotoxicity to eukaryotic cells, in 
contrast to tunicamycin. Many of these compounds have potent antimicrobial activity with 
IC50 values ranging from 10-70 nM and MICs as low as 1 µg/mL on gram-positive bacteria 
such as methicillin-resistant S. aureus and vancomycin-resistant E. faecium [24]. 
Generally, highly-modified nucleosides are effective against gram-positive strains. This 





The biosynthetic pathways of these highly-modified nucleosides involve an array 
of unusual enzyme chemistry, all starting with canonical UMP. From UMP, large scaffolds 
with multiple stereocenters are installed. These compounds are often appended to other 
biosynthetically derived components, such as nonribosomal peptides and polyketides. 
Biochemical characterization of this catalysis is essential, as bioinformatics commonly 
yields inaccurate data with such small training sets. 
Oxidative dephosphorylation is the first step in these nucleoside biosynthetic 
pathways. This is carried out by a nonheme, Fe(II)-, α-KG-, oxygen-dependent 
dioxygenase, transforming UMP into a uridine 5'-aldehyde intermediate. This catalysis was 
probed by Goswami et al (Error! Reference source not found.); it was found that a single 
































































































































Figure 1.3 Select GlyU-ADR nucleoside antibiotics. Components include: GlyU-ADR 




At this point, the pathway splits. Uridine 5'-aldehyde is utilized in two ways. For 
one, it can be converted into GlyU by a transaldolase (LipK) [29]. The other way is via a 
typical PLP-dependent transamination, forming 5'-amino-5'-deoxy-uridine. A 
phosphorylase and nucleotidyltransferase will activate the modified ribose sugar (ADR). 
Then, a glycosyltransferase can join GlyU and the activated ADR to make the GlyU-ADR 
disaccharide core (Figure 1.5) [15, 30, 31]. 
Figure 1.4 Dioxygenase LipL activity and the phosphonate UMP analog used to probe the 




Before further scaffold extension, there is evidence that all homologous 
biosynthetic pathways require phosphorylation at the 3''-position by a kinase (e.g. the 
recently characterized Mur28 of muraymycin biosynthesis) [32]. This is hypothesized to 
be part of a self-resistance mechanism, as antibacterial activity of the phosphorylated 
intermediates is significantly hindered [32]. Protecting the producing strain during 
biosynthesis this way is has been observed before, for example during caprazamycin 
production [33]. 
1.5 Sphaerimicin: the most recently discovered GlyU-ADR-containing natural 
product 
The most recently discovered nucleoside antibiotic containing a GlyU-ADR core is 
the sphaerimicins. Sphaerimicins A-D have been isolated from Sphaerisporangium sp. 
SANK 60911 using a structure-based gene targeting screen [24]. Sphaerimicin A has been 



































































Figure 1.5 Biosynthesis of GlyU-ADR shared among this subset of highly-modified 
nucleosides. Two canonical UMP molecules can be transformed into the GlyU-ADR core 
of these large nucleoside antibiotics using 6 enzymatic steps. 
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dihydroxylated piperidine bridged to the 5''-amine of a 5-amino-5-deoxyribose moiety. 
This compound exhibits effective MICs against a variety of bacterial strains and possess 
potent IC50 values against MraY [24]. 
Table 1.1 MIC values of sphaerimicin A against a range of bacterial strains. 
Organism MIC (µg/mL) 
Streptococcus pneumoniae ATCC 49619 (THB) 1 
Streptococcus pneumoniae ATCC 49619 (G
+
) 16 
Streptococcus pyogenes ATCC 12344 (G
+
) 16 
Staphylococcus aureus ATCC 6538P (G
+
) 4 
Staphylococcus aureus 10925 (G
+
) 8 
Staphylococcus epidermidis ATCC 14990 (G
+
) 8 
Enterococcus faecalis ATCC 29212 (G
+
) 2 
Enterococcus faecium ATCC 19434 (G
+
) 2 
Moraxella catarrhalis ATCC 25238 (G
-
) 4 
Haemophilus influenzae ATCC 49247 (G
-
) 8 




Table 1.2 IC50 values of several highly-modified nucleoside antibiotics against MraY. 
MraY inhibitor IC50 (nM) 
Muraminomicin F 11.47 
Sphaerimicin A 13.65 
Sphaerimicin B 44.49 
Sphaerimicin C 65.82 




1.6 Contents of the dissertation 
Described throughout this work is how the GlyU-ADR intermediate is initially 
utilized in a similar (but unusual) way in each of these homologous natural product 
biosynthetic pathways. Established herein is a unique PLP-dependent gamma-replacement, 
wherein a Cγ-S bond is broken and a Cγ-N bond is created. This forms the critical N-
alkylamine linker where further tailoring will occur in downstream biosynthesis. First, a 
current understanding of PLP chemistries is reviewed (Chapter 2). Next, studies used to 
probe the mechanism of the PLP-dependent alkyltransfer are described (Chapter 3). 
Finally, preliminary evidence for a few ways the biosynthetic pathways diverge, 
specifically concerning the formation of the dihydroxylated piperidine ring in the 




 CURRENT UNDERSTANDING OF PLP CHEMISTRIES 
2.1 Introduction - pyridoxal 5'-phosphate function & structure 
Pyridoxine (vitamin B6) is a precursor of pyridoxal 5'-phosphate (PLP). PLP-
dependent enzyme catalysis is ubiquitous and incredibly diverse, considering nature has 
used the same coenzyme to fulfill so many different physiological needs. Recently, a study 
estimated that 4% of total enzyme activity requires PLP [34-36]. Additionally, PLP-
dependent enzymes encompass 5 of the 6 enzyme classes categorized by the Enzyme 
Commission of the International Union of Biochemistry (including oxidoreductases, 
transferases, hydrolases, lyases, and isomerases) [34, 35]. More than 230 different enzyme 
activities have been reported for catalysis utilizing PLP, which is done so by electron 
movements enabled by the highly conjugated electron sink of the PLP pyridine ring [37-
42]. This allows for stabilization of carbanions through delocalization of the negative 
charge throughout the conjugated system [43-45]. PLP is used in primary metabolism – 
interconverting alpha-keto acids and amino acids to allow exchange of carbon sources 
between the Kreb’s cycle and amino acid metabolism, as well as cell signaling. For 
example, in the regulation of neurotransmitters, GABA aminotransferase (GABA-AT) can 
catalyze 2-oxobutyrate to L-glutamate. GABA-AT can also interchange between GABA 
and succinic semialdehyde. Another PLP-dependent enzyme, glutamate decarboxylase 
links these two reactions, converting L-glutamate to GABA [46]. This makes PLP central 
to shuttling carbon sources between neural transmission and aerobic metabolism. 
Additionally, PLP-dependent catalysis has been utilized in numerous ways to create a vast 
number of nonproteinogenic amino acids [47, 48]. Clearly, PLP is important to vital 
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cellular functions and has brought about incredibly diverse chemistry achieved through 
acidification and exchange of protons otherwise too unreactive to modify. 
Let’s consider how enzymes typically utilize PLP. First, an internal aldimine will 
form in the enzyme active site typically from a lysine residue in the active site. This is 
followed by an external aldimine forming with the substrate, often an amino acid. From 
here, a number of bonds can be cleaved at the alpha position, wherein the electrons will be 
stored and dispensed via the electron sink of the PLP pyridine ring. Typically, the enzyme 
will bind substrates in a way that the Cα-H bond is held in parallel to the p orbitals of the π 
system [49]. This weakens the bond, lowering vibrational force constants, allowing for 
effective deprotonation [49]. Formation of new linkages can occur with incoming protons 
or a second substrate [40, 42]. Experimentally, different conjugations of PLP bound to 
substrate can be tracked using UV-visible spectroscopy throughout the catalytic cycle, such 
as the formation of the internal and external aldimine. Additionally, a quinonoid forms 
when PLP captures electrons from the substrate and stabilizes this, like after alpha-carbon 
deprotonation, though this is not always possible to observe in the lab setting [50]. 
Proteins direct the diverse chemistry that can take place; active site mutations have 
been demonstrated to modulate activity, such as an aminotransferase acquiring 
decarboxylase-like activity [51]. In another case, a single tyrosine mutant in human and 
Morganella morganii  histidine decarboxylases (hHDC and mHDC, respectively) altered 
the directed chemistry, causing a decarboxylation dependent oxidative deamination to 
occur, rather than the wild-type activity of a simple decarboxylation to form histamine 
(Figure 2.1, [52]). The tyrosine is thought to be responsible for the protonation of the 
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substrate alpha-carbon, allowing for histamine formation once CO2 leaves and the 
quinonoid intermediate is formed. With a phenylalanine mutation, this protonation is 
prevented. Kaminaga et al propose that, in the presence of oxygen, this leads to a peroxy-
aldimine intermediate. Once released from PLP, this peroxy-imidazole ethanamine would 
release hydrogen peroxide, forming imidazole ethanimine. Exchanging with water affords 
the imidazole acetaldehyde product. Thus, a minor loss of a hydroxy group on an active 
site residue converts a decarboxylase into an aldehyde synthase. Nature has evolved to give 
PLP-dependent enzymes a multitude of functionality, capable of acting on amino acid, 
oxoacid, and amine substrates [48]. Through PLP-enabled protonation and deprotonation 
events at alpha-, beta-, and gamma-position carbons of substrates, a variety of eliminations 
and replacements can occur. This greatly adds to the chemical complexity that Nature 
creates and provides crucial synthesis, degradation, and interconversion of amino acids – 

















Figure 2.1 Wild-type HDC activity compared to a critical mutation capable of modulating 
the PLP-depdendent chemistry that occurs. 
 
PLP-dependent enzymes can be divided into five independent classes based on 
fold-type [35]. Alpha family PLP-dependent enzymes (Fold Type I) encompass a 
combination of parallel beta sheets and alpha-helices resembling the aspartate 
aminotransferase homodimer. Often, this fold-type will catalyze a change in covalency at 
the α-position, such as aminotransferases (Figure 2.2) [53], serine hydroxy 
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methyltransferases, and transaldolases (e.g. LipK [29]). Fold Type II structures resemble 
the beta-subunit of tryptophan synthase. These Beta family PLP-dependent enzymes (Fold 
Type II) typically change covalency at the β-position, including tryptophan synthase β, 
serine dehydratases [53], and SbnA [54]. The alpha family is the largest, followed by the 
beta family [35]. Two smaller families – the D-alanine aminotransferase and alanine 
racemase family – each consist of only a few enzymes (Fold Type III and IV, respectively). 
Lastly, Fold Type V is based on glycogen phosphorylase. This is a unique fold-type, as it 
is the only class of PLP-dependent enzymes that does not go through a geminal diamine 
intermediate between the deprotonated substrate amine and the internal aldimine Schiff 
base [35]. Many PLP-dependent enzymes do not fit into any of these families functionally, 
such as various amino acid racemases and decarboxylases (Figure 2.3), as well as ACC 
synthases involved in ethylene biosynthesis [53, 55]. PLP-dependent enzymes probably 
diverged into distinct classes based on the chemistries they perform – later diverging 
further based on substrate specificity [42]. Aminotranferases and decarboxylases can be 
found in multiple lineages, suggesting convergent evolution [42]. PLP likely emerged early 
in biological evolution, before divergence of eukaryotes and archebacteria 1500 million 
years ago [42]. PLP can form an “external” aldimine in the absence of the enzyme-PLP 
internal aldimine. For example, PLP reversibly binds L-Met to form an aldimine with a Kd 
of 3.6 mM at pH 7.5 [56]. The first biological catalysts may have been metal ions and 
organic cofactors that coordinated the useful electron-sink molecule [42]. Described below 
are some of the known α, β, and/or γ elimination and addition catalytic strategies employed 





2.2 Alanine racemase 
Though the alanine racemase family constitutes a small portion of PLP-dependent 
enzymes, mechanistic studies into such enzymes have given significant insights into PLP-
dependent catalysis. Alanine racemase is the enzyme responsible for the interconversion 
between D- and L-isomers of alanine (Figure 2.4). Michael Toney et al have explored 
alanine racemases from Bacillus strains, finding that during L- to D-isomerization an active 
site Tyr265 residue is responsible for proton abstraction from L-Ala and a Lys39 residue is 
used for reprotonation. During D- to L-isomerization, the Lys39 residue deprotonates and 
the Tyr265 residue reprotonates [41, 57-60]. 
Figure 2.2 General aminotransferase mechanism. First, the alpha-position is deprotonated; 
this drives electrons into PLP, affording the quinonoid intermediate; next, water is utilized 





















Figure 2.3 General decarboxylase mechanism. In this case, the electron sink stabilizes the 
carbonanion at the alpha-position; because of this stabilization, carbon dioxide can be 
eliminated from the reactant. 
16 
 
Contrary to the PLP resonance previously described, the full extent of the PLP 
electron sink is not utilized during this alanine racemase activity. In many PLP-dependent 
enzymes, a conserved aspartate residue in the active site nearby the pyridine nitrogen helps 
maintain a formal positive charge. This creates an electronic environment that causes an 
intramolecular interaction where the hydroxyl of PLP hydrogen bonds with the aldimine 
nitrogen, causing it to mostly exist in a protonated state [61]. In alanine racemases studied 
here, an Arg219 residue interacts with the pyridine nitrogen. The basicity of guanidine 
group of arginine prevents the pyridine from being formally protonated [62]. This is 
reflected in structural studies [40, 44, 63] and the inability to detect the diagnostic UV 
spectra of a quinonoid intermediate during catalysis [41]. Though this destabilizes the 
carbanionic intermediate, the mechanism still proceeds through a stepwise model of 
protonation and reprotonation, rather than a concerted double proton transfer, which would 
bypass the need for a carbanionic intermediate to exist. This seems counterintuitive – 
destabilizing the conjugation system of PLP, even though the alanine racemase mechanism 
proceeds through the typical carbanionic intermediate. Toney et al hypothesize that this 
may serve to avoid side reactions such as transamination, which is seen in other PLP-
dependent racemases that lack an arginine residue in proximity to the nitrogen pyridine and 
possess the typical charged state [62, 64, 65]. The aldimine nitrogen must still be 
protonated to activate it for nucleophilic attack of the substrate; this is called 
transamination, which often creates a geminal diamine intermediate. Based on 15N solid-
state NMR studies, it is thought that this activation is instead achieved through protonation 
(or strong OHO hydrogen-bonding) of the pyridine hydroxyl [61]. This means there are 
two modes of internal aldimine activation – through either N- or O-protonation. Toney et 
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al has also explored the importance of small, femtosecond time scale active site protein 
motions in alanine racemase catalysis. 
The Born-Oppenheimer approximation states that isotopic substitution only alters 
vibrational frequency, leaving electrostatic properties unaltered. Vern Schramm pioneered 
using this principle to disrupt femtosecond motion of HIV-1 protease and purine nucleoside 
phosphorylase. While loop and domain motions at micro- to milli-second time scale are 
central to providing catalytically productive environments (e.g. opening and closing active 
site as needed), smaller protein motions surrounding the active site in the femto- to pico-
second time scale are involved in transition state barrier crossing. Using “heavy enzymes” 
with major incorporation of heavier isotopes into the peptide sequence (i.e. kinetic isotope 
effect, KIE), Schramm et al demonstrated that bond vibrations near the catalytic site in this 
time scale play a role in transition-state formation [66-69]. This disruption is caused by 
local heavy atoms in the catalytic site leading to a reduced probability that the enzyme 
finds proper enzymatic transition state conformation. 
Michael Toney et al have applied a similar approach to alanine racemase. This is a 
novel addition to this area of research as this was the first time heavy-enzyme KIEs were 
used to observe an enzyme-catalyzed reaction where proton transfer was the rate-limiting 
step (a common motif in PLP-dependent reactions [40, 45, 59, 70, 71]). Toney et al studies 
showed that isotope effects from enzyme and substrate deuteration are not independent of 
each other, indicating that these two species are coupled in the rate-limiting event [72]. 
This means that femto-second protein motion during proton transfer is critical to transition 
state barrier crossing. Additionally, they found that intrinsic KIEs are relatively small in 
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either direction of catalysis (1.66 and 1.57 for the L to D and D to L conversion, 
respectively). This is likely owed to proton tunneling between the alpha-carbon and either 
residue responsible for proton transfer (Tyr265 or Lys39 acting as the acid-base catalysts 
in their studies with Geobacillus stearothermophilus, like their previous studies in Bacillus 
alanine racemases) [65, 72]. Together, this mechanistic work shows that protein residues 
and small femtosecond time scale conformational changes in the active site aid in directing 








































D-Ala + E-PLPL-Ala + E-PLP
 
Figure 2.4 PLP-depedent mechanism of alanine racemase depicted. Residues on opposing 
sides of the substrate allow interconversion between stereoisomers. 
 
2.3 γ-addition and elimination catalysis 
2.3.1 Cystathionine gamma-synthases / lyases and LolC 
Transsulfuration and reverse transsulfuration are critical de novo pathways for L-
cysteine and L-homocysteine interconversion, respectively [73, 74]. Transsulfuration, 
critical in plant and bacterial metabolism, uses cystathionine gamma-synthase (CGS) and 
cystathionine beta-lyase (CBL) to interconvert between L-cysteine / O-succinyl-L-
homoserine and cystathionine [75]. In fungi, cystathionine-gamma-synthase catalyzes C-
C bond breaking and a C-S bond formation [47]. Overall, the gamma-elimination of O-
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acetyl- L-homoserine gives a vinylglycine ketimine, which is subject to the nucleophilic 
attack of the thiol group of cysteine. In contrast, reverse transsulfuration of mammalian 
and fungal metabolism, uses cystathionine beta-synthase (CBS) and cystathionine gamma-
lyase (CGL) to interconvert between L-homocysteine / L-serine and cystathionine [74]. 
Mammalian and fungal CBS utilizes homocysteine and serine for form cystathionine 
through beta-replacement. CGL performs an alpha, gamma-elimination on cystathionine, 
yielding cysteine, 2-oxobuytrate, and ammonia. Plant and bacterial CGSs catalyze the 
replacement of substituents at the γ-position of amino acids through a common α-proton 
exchange as well as a rapid β-proton exchange [76].  
CGSs can utilize OSHS or L-VG as a C4N donor to form cystathionine in the 
presence of the C4N acceptor cysteine (γ-replacement product, Figure 2.5) [77]. Without a 
C4N acceptor present, both OSHS and L-VG can form 2-oxobutyrate through an 
aminocrotonate-PLP intermediate (γ-elimination product) [78]. There is evidence that the 
CGS reaction yields the Z-conformation in the L-VG-PLP intermediate [79]. Conversely, 
cystathionine gamma-lyase catalyzes the alpha, gamma-hydrolysis of L-cystathionine to 
form L-cysteine and 2-oxobutyrate. Remarkably, N360S mutation in the parasite 
Toxoplasma gondii cystathionine gamma-lyase (TgCGL) changes the specifity of 
elimination. This modification directs catalysis to perform an alpha,beta-elimination, rather 
than the alpha, gamma-elimination found in wild type TgCGL [73]. LolC, a critical enzyme 
in loline alkaloid biosynthesis, is proposed to have similar activity to CGS, creating a new 





2.3.2 Alkyl transfer in nucleoside antibiotic biosynthesis 
Another PLP-dependent γ -replacement catalytic strategy for transferring a C4N 
group was recently reported. An aminobutyrate transferase employ Cγ-S bond breaking and 
Cγ-N bond formation – a greater feat in regards to nucleophilicity compared to the CGS 
Cγ-O bond is breaking and Cγ-S bond formation [81, 82]. Evidence shows that these 
ABTases, such as Mur24, cannot utilize L-VG as an alternative donor, an interesting 
distinction from CGS that perform similar chemistry [78]. Analogous to CGS, α-KB/2-
oxobutyrate is formed in the absence of the C4N acceptor, making it a reasonable 
hypothesis that γ-replacement and -elimination reactions diverge from a common 
intermediate (proposed to be L-VG, like CGS). The sequence similarity suggests 





















Figure 2.5 CGS reaction, wherein homocysteine of OSHS is eliminated and used in the 















Figure 2.6 Proposed LolC activity. An analogous mechanism to CGS; however, a nitrogen 
heteroatom is used to form a new Cγ-N bond. 
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more in common with CGS mechanistically as indicated by proton exchange experiments 
with substrate isotopologues and reactions conducted in D2O [82]. First, the alpha-proton 
is abstracted (as in many PLP-dependent enzymes). This is likely followed by immediate 
C4' protonation, generating ketimine II. This is indicated by difficulty in measuring any 
quinonoid formation during Mur24 catalysis. Now more acidic due to the vicinal iminium, 
the beta-proton is abstracted forming enamine III. Subsequently, the beta, gamma-
unsaturated ketimine IV is formed as MTA is eliminated. The amine nucleophile (i.e. 
nucleoside intermediate) is deprotonated and attacks the gamma-carbon in an aza-Michael-
like addition (described in Chapter 3). It is possible that Lys234 of Mur24 is responsible 
for internal aldimine formation, alpha- and beta-proton transfers [82]. The natural alkyl-
donor substrate of both ACC synthases and nucleoside ABTases is AdoMet [83]. Similar 
to loline alkaloid biosynthesis, a simple methyltransferase-like SN2-type substitution looks 
possible (such as that seen in polyamine biosynthesis like spermidine [82, 84]), but the 
chemical strategy to transfer this group is much more intricate. This mechanism is further 
explored in the contents of this dissertation in Chapter 3. 
2.3.3 Formation of alkyl-substituted pipecolate in citrinadin and fusaric acid 
biosynthesis 
Pipecolate and derivatives are intriguing building blocks that are frequently used in 
natural products such as rapamycin, where the moiety plays a critical role in target potency. 
Though pipecolate is not an unusual natural compound – found in plant, fungal, and 
microbial biosynthesis – alkyl-substituted pipecolates are very rare. Recently, a two-step 
enzymatic synthesis of (2S,6S)-6-methyl pipecolate was characterized in citrinadin 
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biosynthesis by the Tang lab. First, a gamma-elimination of O-acetyl-L-homoserine occurs. 
This generates vinylglycine ketimine, wherein a nucleophilic attack by acetoacetate will 
create a new carbon-carbon bond. This full gamma-replacement is catalyzed by a single, 
PLP-dependent enzyme, CdnF (Figure 2.7), which has sequence similarity to 
cystathionine-gamma-synthase. This is in equilibrium with a cyclic Schiff base, which is 
the substrate for the stereoselective imine reductase, CndE [85]. CndF was shown to form 
an internal aldimine with a lysine residue, typical of many PLP-dependent enzymes. The 
mechanism of this route is distinct from typical pipecolate biosynthesis, which leads to an 
aliphatic carbon at the position where alkyl-substitution would need to occur [86]. 
CndF shows a flexible substrate specificity toward the nucleophile. Though the 
natural substrate is acetoacetate, CndF can accept 6 beta-keto carboxylate and ester 
substituted substrates [85]. This shows that decarboxylation of the acetoacetate is not 
required for enol formation, meaning that a general base in the active site must be 
responsible for abstracting the alpha-proton of the beta-keto substrates. With respect to 
medicinal chemistry, this is interesting because the R-group (naturally a methyl group) of 
the CndE product is in the mature natural product following NRPS-modification and 
tailoring reactions. This means that CndF could potentially be used with various substrates 
for compound optimization (although this would currently be limited due to downstream 
specificity in the biosynthetic pathway). With respect to enzymology, this is interesting 
because (though it is mechanistically analogous to cystathionine-gamma-synthase) this 




More recently, the Tang lab has characterized another Cγ-O bond breaking and Cγ-
C bond forming PLP-dependent enzyme Fub7 in fusaric acid biosynthesis. 
Biosynthetically, Fub7 catalyzes a gamma-replacement reaction, converting O-acetyl-L-
homoserine and n-hexanal to acetate and (2S)-2-amino-5-formylnonanoic acid (Figure 2.8, 
[87]). This is a chemically intriguing reaction. PLP-dependent enzymes using aldehyde 
substrates often use them as electrophiles, however, in this cause the enolate tautomer of 
n-hexanal is used as a nucleophile. This product is in equilibrium with the cyclic 
unsaturated pipecolate, a precursor to fusaric acid [87]. Using Fub7, the group 
chemoenzymatically synthesized a series of pipecolate analogues including 5-alkyl-, 5,5-






































Figure 2.7 CndF activity using PLP-dependent gamma-replacement chemistry to break a 






































































































































Figure 2.8 Fub7 uses PLP-dependent gamma-replacement to break a Cγ-O bond and 
create a Cγ-C bond; unlike CndF, catalysis uses an aldyhyde substituent via enolate 
reactivity. 
 
2.3.4 The γ-elimination, α-addition (Claisen Condensation) catalysis of CqsA 
PLP-dependent enzymes yielding a γ-replacement first make a stabilized α-
carbanion, followed by a deprotonation at the newly acidic Cβ-position. This leads to the 
leaving of the γ-substituent, creating a fully conjugated intermediate with electrophilicity 
at the Cγ [79]. Catalysis can also include a mix of elimination and addition at varying 
positions, such as the loss of γ-elimination and α-addition (acyltransfer activity) of CqsA 
involved in Vibrio cholera autoinducer-1 biosynthesis [89]. 
CqsA is critical to the biosynthesis of the quorum-sensing signal CAI-1, coupling 
S-adenosyl-L-methionine (AdoMet) and decanoyl-coenzyme A to form a CAI-1 precursor, 
Ea-CAI-1. Catalysis combines the γ-elimination of the MTA moiety of AdoMet, forming 
a vinylglycine-PLP intermediate. This will then undergo an acyltransferase reaction, 
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leading to the addition of a decanoyl moiety at the α-position (Figure 2.9). This was a novel 
addition to the known biosynthetic arsenal, as an enzyme capable of doing both of these 
catalytic transformations in one active site had previously been unheard of entirely [89]. 
Undoubtedly, the use of AdoMet as a cosubstrate in enzymatic reactions has led to 
interesting chemistries. For example, using AdoMet as an alkyl-donor in spermidine 
biosynthesis, as well as the more mechanistically intriguing PLP-dependent alkyl-transfer 
of CAI-1 and nucleoside antibiotic biosynthesis. This makes for an excellent example of 
how Nature has evolved strategies to leverage such an abundant molecule stereotypically 
reserved for amino acid metabolism and methyltransferase reactions. Another unusual use 
of AdoMet is the cyclization of the aminobutyrate substituent in colibactin biosynthesis 
[90, 91], as well as the PLP-dependent chemistry is found in ethylene biosynthesis.  
 
2.3.5 The γ-elimination of 1-Aminocyclopropane-1-carboxylic Acid Synthases 
1-Aminocyclopropane-1-carboxylic acid synthases (ACC synthases) are essential 





































Figure 2.9 CqsA mechanism wherein AdoMet is utilized in a gamma-elimination, 
breaking a Cγ-S bond; this is followed by alpha-addition acyltranfer-like activity. 
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other regulative processes. ACC synthases catalyze Cα-Cγ bond formation and Cγ-S bond 
cleavage of AdoMet to form ACC and MTA (Figure 2.10), the rate-limiting step in 
ethylene formation. Evidence suggests that, unlike CGS, Cβ protons do not participate in 
the reaction [55]. This is an interesting part of the mechanism distinct from the ABTases 
described in this dissertation, as they share the most sequence similarity with ACC 
synthases but do appear to utilize Cβ protons. Unexpectedly, an ACC synthase has also 
been functionally characterized from the guangnamycin biosynthetic pathway (a bacterial 
producing strain) [92]. Oddly, a gene in humans has been found encoding a putative ACC 
synthase, though studies thus far have only shown activity toward deaminating VG [93]. 
We propose that he lysine residue essential to alpha-carbon deprotonation is quickly pulled 
away from the catalytic region via a glutamate residue via electrostatic interactions. This 




































Figure 2.10 ACC synthase mechanism wherein the alpha-carbon is deprotonated by a 
neighboring lysine residue, forming a ketimine intermediate. The electron movement is 
reversed, leading to the ketimine pi electrons to attack the gamma-position (thereby breaking the 
Cγ-S bond and forming the cyclopropane ring. 
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2.3.6 PLP-dependent gamma-elimination in alkyne functional group biosynthesis 
Six enzymes are utilized during the formation of beta-ethynylserine from L-lysine 
in S. cattleya. One of these enzymes, BesB is PLP-dependent with sequence similarity to 
the cystathionine-beta-lyase/cystathionine-gamma-synthase family. Once the halogenase 
and oxidase, BesD and BesC, respectively, chlorinates and oxidatively cleaves L-lysine, 
BesB catalyzes the gamma-elimination of chloride from 4-chloro-allyl-L-glycine to form 
an L-propargylclycine intermediate (Figure 2.11). In probing the BesB mechanism, a 
deuterium exchange was monitored with high-resolution mass spectroscopy. Using 4-
chloro-allylglycine as a substrate in D2O, [M+2D]+ L-propargylclycine was detected, which 
would indicate a mechanism analogous to other PLP-dependent gamma-eliminations 
requiring two deprotonation-protonation events. It is proposed that alpha-carbon 
deprotonation forms a 4-chloro-allylglycine-ketimine intermediate. A second, beta-carbon 
deprotonation initiates the chloride elimination, possibly forming an allene intermediate 
that is isomerized into the final propargyl group [94]. This could be instrumental in the 





























Figure 2.11 BesB in the context of beta-ethynylserine biosynthesis in which the PLP-
dependent gamma-elimination of chlorine leads to alkyne formation. 
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2.4 Beta-addition and -elimination catalysis 
2.4.1 Beta-replacement in lanthionine biosynthesis 
Lanthionine synthase, a homologue of O-acetylserine sulfhydrylase (OASS), 
catalyzes the beta-replacement of L-cysteine with another molecule of L-cysteine, releasing 
H2S and L-lanthionine [95, 96]. This is achieved first through typical internal aldimine 
formation with a lysine residue. Once the external aldimine is formed with L-cysteine, 
proton transfer between the alpha-carbon and the same lysine residue leads to the release 
of H2S and formation of ketoenamine and enolimine intermediates in resonance. Next, the 
addition of another L-cysteine molecule leads for the formation of L-lanthionine [96, 97]. 
This reaction is highly similar to cystathionine beta-synthase (CBS), however lanthionine 
synthase prefers formation of lanthionine as a product, while CBS prefers cystathionine 
(both are capable of making either product to an extent) [98]. Wolthers et al found that a 
S224A lanthionine synthase mutant changes this ratio of product formation, increasing 
turnover rate at the cost of catalytic preference for L-lanthionine formation.  Product 
formation changes from a 2:1 ratio of lanthionine formation over cystathionine, to a 1:1 
formation of mixed product. This indicates that the presence of the serine residue in the 
active site is critical for binding specificity of the second substrate (creating a preference 
of a second L-cysteine molecule over L-homocysteine, like in CBS catalysis). Likely, this 
is a case where Nature has evolved to prefer specificity over efficiency. 
29 
 
2.4.2 Beta-replacement in viomycin and staphyloferrin biosynthesis 
VioB, a 2,3-diaminopropionate synthase from viomycin biosynthesis, utilizes L-
serine/O-acetyl-L-serine to create L-2,3-diaminopropionate. Sharing homology to cysteine 
synthases and serine dehydratases, VioB facilitates a PLP-dependent beta-substituent 
replacement and elimination. VioB has a unique nucleophile; while most PLP-dependent 
enzymes use a thio- or amino-nucleophile (often on other amino acids such as cysteine), 
VioB uses free ammonia in solution (possibly generated by another enzyme in the 
































Figure 2.12 VioB PLP-dependent activity, where beta-elimination is followed by beta-
addition at using free ammonia nearby during catalysis. 
 
SbnA is responsible for the first step in the biosynthesis of the siderophore, 
staphyloferrin B. Catalysis coverts O-phospho-L-serine and L-glutamate to N-(1-amino-1-
carboxy-2-ethyl)-glutamic acid (Figure 2.13) [54]. As expected, SbnA creates an 
absorption spectrum of 412 nm in the presence of PLP (indicative of an internal aldimine 
forming with a lysine residue in the active site. Though there is homology to VioB, only 
O-phospho-L-serine was a substrate for SbnA, rather than L-serine/O-acetyl-L-serine. Upon 
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addition of O-phospho-L-serine, an external aminoacrylate intermediate is formed, as 
indicated by a shift in the UV-Vis spectrum to a 324 and 467 nm peak [100]. 
 
2.4.3 The β-elminination catalysis of serine dehydratase 
Serine dehydratases perform a β-elimination of the hydroxyl group of serine. It was 
found that a conformational change in PLP was essential for nucleophilic attack of the 
substrate, as well as concerted α-proton transfer from the substrate to a protein residue in 
the active site and directing substrate carbanion formation [38]. 
2.4.4 Beta-decarboxylation 
Although much less common, beta-decarboxylation has been studied. Most novel 
of these is UstD – from the ustiloxin B biosynthetic pathway of the pathogenic fungus, 
Ustilaginoidea virens. In this catalysis, the beta-decarboxylation of aspartate leads to 
formation of an enamine. This enzyme activity is unique, because the enamine formed is 
reacted with an aldehyde substrate in the same active site [101] (Figure 2.14). Though this 
bi-bi ordered sequential PLP-dependent replacement chemistry is typical in gamma-


















Figure 2.13 SbnA catalyzes beta-replacement chemistry, wherein a Cβ-O bond is broken 


























Figure 2.14 PLP-dependent beta-replacement, wherein carbon dioxide is first released 
from the substrate. 
 
2.4.5 PLP-dependent Thiol Formation 
Methionine gamma-lyase (MGL) is commonly associated with L-methionine 
catabolism, decomposing L-methionine to methanethiol, 2-oxobutyrate, and ammonia. 
Interestingly, MGL is also capable of the beta-elimination of S-substituted cysteines, 
generating the respective alkylthiol, pyruvate, and ammonia. In the case of Citrobacter 
intermedius MGL, a Tyr 113 residue plays a critical role in gamma-elimination, whereas a 
Tyr58 residue plays a critical role in beta-elimination [102]. This contrasts with the more 
recently discovered C-S lyase from Lactobacillus delbrueckii (a lactic acid bacterium). 
This C-S lyase has broad substrate specificity (aminoethyl-L-cysteine, L-cystine, L-
cysteine, L-cystathionine) but appears to only be capable of beta-elimination [103]. As seen 
with lanthionine synthases, single protein residues can play a critical role in substrate 
specificity. In the case of Pseudomonas putida MGL, a C116H renders the enzyme 
completely inactive toward the L-cysteine and L-methionine (the wild-type substrates), but 
opens up activity to L-homocysteine [104]. 
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2.5 The α-replacement catalysis of transaldolases in production of beta-hydroxy-
alpha-amino acids 
LipK, a transaldolase from the A-90289 biosynthetic gene cluster, joins L-threonine 
and uridine 5'-aldehyde in the biosynthesis of a particular subset of nucleoside antibiotics 
to form a GlyU precursor through alpha-replacement chemistry (Figure 2.15). Initially 
annotated as a SHMT, LipK has distinct regions in the protein sequence that differentiate 
its activity from bona fide SHMTs [29]. Classically, SHMTs are used to convert glycine to 
serine using THF as a C1-unit donor. LipK was the first enzyme found to do this unusual 
formation of a β-hydroxy, α-amino acid using a uridine precursor, creating two new 
stereocenters in the process. There is a whole class of enzyme homologues capable of 
analogous catalytic activity; notably, AbmH of albomycin biosynthesis uses a thioheptose 
nucleoside intermediate [105]. 
 
2.6 PLP-dependent oxidation catalysis 
PLP-dependent enzymes can also perform oxidation chemistry, such as oxidative 






















Figure 2.15 Transaldolase (LipK) mechanism constituting an alpha-elimination of acetaldehyde 
and addition of an amino acid, leading for the formation of GlyU. 
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MppP from the mannopeptimycin biosynthetic pathway, which is partially responsible for 
the formation of L-enduracididine. There is evidence that MppP converts L-arginine and 
dioxygen to (S)-4-hydroxy-2-ketoarginine via unusual PLP-, O2-dependent chemistry. 
Interestingly, even though O2 is required- it is not incorporated into the product. Instead, 
the hydroxyl and ketone oxygen atoms are derived solely from water, while the dioxygen 
molecule is reduced to H2O2 [106]. Mannopeptimycin, teixobactin, and enduracidin are all 
nonribosomal peptide antibiotics that bind the lipid II intermediate during peptidoglycan 
cell wall biosynthesis (similar to vancomycin mode of action, but different binding 
interactions) [107]. Ind4, from the indolmycin biosynthetic pathway, has been shown to 
catalyze a similar 4-electron oxidation of L-arginine, forming 4,5-dehydroarginine [108] 
An Ind4 homolog, RohP, has recently been discovered to have activity similar to MppP in 
which an oxidized and hydroxylated product is formed (Figure 2.16) [109]. A distinctly 
different PLP-, O2-dependent mechanism for oxidation has been proposed for CuaB most 
recently. Similar to RohP, water is suggested to be the oxygen source, however CuaB 
seems to perform an α-addition, decarboxylation, and hydroxylation in one catalytic cycle 
(Figure 2.17) [110]. Cap15, a monooxygenase-decarboxylase from the capuramycin 
biosynthetic pathway, performs a very different oxidation reaction. This reaction converts 
an α-amino acid into a carboxamide. In the case of Cap15, an oxygen from O2 is 
incorporated into the substrate in a PLP-dependent catalysis (Figure 2.18) [37]. 
Characteristic of most PLP-dependent reactions, PLP is thought to stabilize the conjugated 




Katherine Ryan et al discusses how these PLP-dependent enzymes utilizing 
molecular oxygen as a cosubstrate are found multiple protein families. They suggest this 
may indicate that this type of catalysis could be directed in other non-related PLP-







































































































































































































































































































The chemical diversity capable solely through utilizing PLP as a coenzyme in 
enzymology is impressive. Nature has evolved a multitude of ways to direct this reactivity 
into branching mechanistic pathways. Understanding the full extent to which PLP is 
utilized in nature is beneficial to both expanding the library of biosynthetic gene clusters 
and natural products, as well as furthering the potential of PLP-dependent chemistry in 
synthetic biology. Some discoveries in thermophilic PLP-dependent enzymes has opened 
the possibility of using high temperatures and significant concentrations of organic solvents 
(e.g. ethanol, methanol, DMSO, and acetonitrile) during catalysis, as these enzymes are 
able to retain catalytic activity. This opens the possibility of using PLP-dependent 
chemistry with a wider variety of nonpolar substrates [112, 113]. Classifying PLP-
dependent enzymes based on sequence can be challenging. To streamline this, Stephanie 
Sieber et al have worked on generating cofactor probes (PLP mimics) that cells can uptake 
and metabolize in situ. These probes can then bind to unknown PLP-dependent enzymes 
and, with NaBH4, be rendered irreversible. Through these studies, they found that 29% of 
known PLP-dependent enzymes are still poorly characterized, with many more still 
undiscovered entirely [113, 114]. This means that more investigation into PLP-dependent 
enzymes has great potential.
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 EVIDENCE OF AN UNUSUAL MECHANISM FOR AN AMINOBUTYRIC ACID 
TRANSFERASE 
3.1 Introduction 
Highly-modified nucleosides are a diverse group of natural products. Their 
biological activity can vary from antiviral reverse transcriptase and RNA polymerase 
inhibitors to antibacterial translocase I inhibitors. One group of highly-modified 
nucleosides inhibiting bacterial translocase I contains a disaccharide core that consists of a 
5''-amino-5''-deoxyribose (ADR) glycosylated (5'S, 6'S)-5'-C-glycyluridine (GlyU). This 
ADR-GlyU core is represented by FR-900493, caprazamycin B, A-90289 B, sphaerimicin 
A, and muraymycin D1 and D2. All share a 6'-N-alkylamine linker that can be appended 
to a variety of other natural products such as glycosylated fatty acids, polyketides, or 
nonribosomal peptides. The ADR-GlyU biosynthesis has been described previously, 
wherein six enzymes form the disaccharide core using UMP and L-Thr [18, 27, 29-31]. 
Bioinformatic analysis suggests that this part of the biosynthetic pathway is shared among 
the group [24]. 
Most recently, the 6'-N-alkylamine linker was found to have a similar biosynthetic 
origin in these homologous nucleoside biosynthetic pathways. Utilizing a muraymycin-
producing mutant strain, Streptomyces NRRL30475, feeding experiments were conducted 
with isotopically labeled precursors. Analysis of this study revealed L-Met to be the origin 
of the C3N unit [82]. Mur24 (from the muraymycin biosynthetic pathway) was functionally 
assigned as a pyridoxine-5'-phosphate (PLP)-dependent AdoMet:phospho-ADR-GlyU 
aminobutyric acid transferase (ABTase), responsible for the γ-replacement of AdoMet by 
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breaking the Cγ-S bond and generating a new Cγ-N bond with the nucleoside intermediate 
(Figure 3.1) [82]. Interestingly, the phosphorylated version of ADR-GlyU, a cryptic 
intermediate formed by Mur28, was found to be the only adequate acceptor substrate of 
Mur24 [32, 82]. Though not apparent from the structure, the same strategy is used to form 
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Figure 3.1 Functional characterization of Mur24 led to the discover of a PLP-dependent 
alkyltransferase that performs γ-elimination and γ-addition in a single active-site. 
PLP offers incredible chemical versatility to enzymes, where protein structure can 
direct an array of reactivity. This is likely why PLP-dependent enzymes encompass 5 of 
the 6 enzyme classes categorized by the Enzyme Commission of the International Union 
of Biochemistry (including oxidoreductases, transferases, hydrolases, lyases, and 
isomerases), accounting for more than 230 distinct enzyme activities [34, 35, 37-42]. This 
activity is enabled by the highly conjugated electron sink of the PLP pyridine ring, allowing 
the stabilization of carbanions through delocalization of the negative charge throughout the 
conjugated system [34, 35, 37-45]. In total, around 4% of total enzyme activity utilizes 
PLP [34-36]. 
The PLP-dependent alanine racemase mechanism has been explored extensively. 
Through observing the kinetic isotope effects (KIEs), wherein heavy atoms with lower 
vibrational frequency are utilized to perturb reactivity, the proton transfer at the alpha 
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position was found to be the rate-limiting step  with marginal KIEs reported between 1.2-
1.7 [40, 45, 59, 70, 71]. With the discovery of the new ABTase, along with knowing that 
primary KIEs indicate a rate-limiting or subsequent product-determining step, we looked 
to understand the mechanism of this unusual gamma-replacement in a similar manner. In 
doing so, we propose that this new family of ABTases likely proceed through a γ-
elimination, γ-addition mechanism, capable of a half-reaction uni-bi ordered sequential 
mechanism, wherein both paths release methylthioadenosine (MTA) as the first product. 
Using AdoMet isotopologues, KIEs across a range of pH and temperatures highlight that 
the rate-limiting step is Cα deprotonation, though Cβ is also perturbed by a deuterium 
isotope effect. Additionally, protein modeling and D2O “wash-in” experiments and D2O 
isotope effects of the half-reaction allude to the possibility of two parallel pathways after 
γ-elimination of MTA for offloading product in the absence of acceptor substrate (9) – both 
a prototropic and sigmatropic rearrangement. 
3.2 Materials and Methods 
3.2.1 General experimental procedures 
UV spectra were recorded on a FLUOstar Omega plate reader (BMG LABTECH 
GmbH, Offenburg, Germany). An Agilent 6120 Quadrupole MSD mass spectrometer 
(Agilent Technologies, Santa Clara, CA) equipped with an Agilent 1200 Series Quaternary 
LC system and Eclipse XDB-C18 column (150 x 4.6 mm, 5 μM) was utilized for LC-MS 
analysis. HR-ESI-MS spectra was recorded on an Agilent 6230 TOF equipped with an 
Agilent 1260 Infinity II LC system and Phenomenex Gemini C18 column (100 x 3 mm, 3 
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μM). All solvents used were of LC-MS grade and purchased from Pharmco-AAPER 
(Brookfield, CT). MassHunter’s Qualitative Navigator was used for all HRMS analysis. 
FPLC was performed on a GE AKTA system with a Superdex 200 Increase 10/300 GL 
size exclusion chromatography column. 
3.2.2 Cloning, overexpression, and purification of proteins 
The gene sphL was synthesized and provided by Zhaoyong Yang. The expression 
construct for the gene hMat2A was provided by Prof. Chunming Liu. The gene mur24 was 
amplified from genomic DNA extracted from Streptomyces sp. NRRL30473, provided by 
Dr. Zheng Cui. All genes were amplified by PCR using Phusion DNA polymerase from 
Thermo Scientific with the supplied HF buffer (Thermo Scientific, Rockford, IL) and 
primers synthesized by Integrated DNA Technologies (Coralville, IA; SI Table 3.1). 
Purified PCR products were ligated into pET30 Xa/LIC (Novagen, Darmstadt, Germany), 
pET28a, or pXY200 using standard digestion and ligation protocol. Plasmids were 
confirmed by DNA sequencing (ACGT, INC, Wheeling, IL). 
Plasmids pET28a-hMAT2a, pET30-lipJ, and pET30-sphL were transformed into 
chemically competent E. coli BL21(DE3) cells (New England Biolabs, Ipswich, MA). 
Transformed strains were grown in LB media with 50 μg/mL kanamycin. Cultures were 
grown in 1 L LB media with 50 μg/mL kanamycin at 37 oC until cell density reached an 
OD600 of 0.4-0.6, at which point cultures were cooled to 18oC expression was induced with 
0.1 mM IPTG. Cells were harvested after 12-18-hour incubation at 18oC, 250 rpm, and 
lysed in Buffer A (100 mM KH2PO4, 300 mM NaCl, pH 8.0) using a Qsonica sonicator 
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(Qsonica LLC, Newtown, CT). Sonication protocol comprised of a 2 min sonicating time 
at 40% amplitude with 10 s pulses, separated by 50 s rest/cooling periods. Cell debris was 
pelleted using high speed (14000 rpm) centrifugation. Supernatant was then purified using 
IMAC chromatography with HisPurTM Ni-NTA agarose (Thermo Scientific, Rockford, 
IL). Undesired proteins were washed from the resin with low (10-20 mM) concentrations 
of imidazole spiked in Buffer A. The desired His-tagged protein was then eluted with 200 
mM imidazole spiked Buffer A. Purified proteins were concentrated and a buffer exchange 
using Buffer B (25 mM KH2PO4, 100 mM NaCl, pH 8.0) was completed using forced 
dialysis via Amicon Ultra 10000 MWCO centrifugal filters (Millipore, Burlington, MA). 
This protein solution was drop frozen using liquid nitrogen and stored at -80oC. Extinction 
coefficients were calculated using the ProtParam tool from ExPASY. Protein 
concentrations were determined using a Nanodrop (Thermo Scientific, Rockford, IL) and 
purity was assessed by 12% acrylamide SDS-PAGE.  
Plasmid pXY200-mur24 was transformed into S. lividans TK24 using PEG-
mediated protoplast transformation and plated on R2YE media with 50 μg/mL apramycin. 
After a 6-day incubation at 28oC, positive tranformants were confirmed by colony PCR 
using InstaGene Matrix (Bio-Rad, Hercules, CA). This recombinant strain was then used 
to inoculate 50 mL R2YE media with 50 μg/mL apramycin and incubated for 3 days at 
28oC, 250 rpm. Protein expression was induced with 50 μg/mL thiostrepton and the culture 
was incubated in the same conditions for an additional 24 hours. The cells were then 
'harvested and enzymatically lysed in Buffer A with 4.0 mg/mL lysozyme. After a 30 min 
incubation at 30oC, the suspension was physically lysed using a Qsonica sonicator (Qsonica 
LLC, Newtown, CT). Sonication protocol comprised of a 4 min sonicating time at 40% 
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amplitude with 10 s pulses, separated by 50 s rest/cooling periods. Protein purification and 
storage was as completed as previously described. 
3.2.3 Assay of SphL, LipJ, and Mur24 half-reactions 
Half-reactions were prepared with 50 mM KH2PO4, pH 8.0, 50 mM KCl, 10 mM 
MgCl2, 2 mM aminobutyric acid donor (AdoMet, Ado-Se-Met, or S-methylmethionine), 
40 μM PLP, and 275 nM ABTase (SphL, LipJ, or Mur24). Reactions were incubated at 
22oC overnight. 
Derivatizing agent was used to facilitate effective UV-vis absorbance and 
ionization for mass spectrometry. AQC (a derivatizing agent for amines) was used to bind 
the α-amino group of L-VG. The reaction was terminated with ACN in a 1:1 ratio. Proteins 
were pelleted with centrifugation and supernatant was combined with 0.2 M sodium borate 
buffer, pH 8.8 and 3.0 mg/mL AQC ACN solution in a 1:3:1 ratio. Mixtures were incubated 
at 55oC for 10 minutes, cooled to room temperature, and transferred to autosampler vials. 
Reactions were analyzed using LC-MS with the gradient shown (SI Table 3.2). 
Assays for analysis of 2-oxobutyrate produced during the reaction utilized MBTH 
(a derivatizing agent for α-keto acids) using an adapted method originally described by 
Tanaka [115]. Reactions were terminated using ACN with 4% formic acid in a 1:1 ratio. 
Proteins were pelleted with centrifugation and supernatant was combined with 8 mM 
MBTH aqueous solution in a 2.5:1 ratio. Mixtures were incubated at 50oC for 30 minutes, 
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cooled to room temperature, and transferred to autosampler vials. Reactions were analyzed 
using LC-MS with the gradient shown (SI Table 3.2). 
3.2.4 Mur24 deuterium exchange assay 
For deuterium exchange assays, AdoMet isotopologues were generated in situ 
using ATP, methionine, and hMAT2A. Reactions were prepared with 50 mM KH2PO4, pH 
8.0, 50 mM KCl, 10 mM MgCl2, 2 mM ATP, 1 mM L-Met isotopologue (L-Met, L-Met-2-
d1, L-Met-3,3,4,4-d4, L-Met-2,3,3,4,4-d5-methyl-d3, L-Met-S-methyl-d3, or L-Se- Met), 40 
μM PLP, 1 μM hMAT2A and 275 nM ABTase (SphL, LipJ, or Mur24). D2O “wash-in” 
half-reactions were performed in 62% D2O. Reactions were incubated at 22oC overnight 
and terminated using ACN with 4% formic acid (1:1 ratio to reaction solution). MBTH 
derivatizing protocol and LC-MS gradient described previously was used for analysis. 
3.2.5 Determining the regiochemistry of isotope exchange 
The product of the Mur24 deuterium exchange assay utilizing the L-Met 
isotopologue, L-Met-3,3,4,4-d4, led to the loss of a single deuterium. In order to determine 
the location of this deuterium exchange, reactions were subjected to HCl-catalyzed 
tautomerization (1.5 M HCl, incubated for 1 hour) in conjunction with HRMS. 
Tautomerization in water led to washing out any deuteriums at the beta-position of the 2-
oxobutyrate product, leaving only the deuterium(s) at the gamma-position. 
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3.2.6 MTA product-inhibition assays 
Michaelis-Menten kinetics were measured with similar reaction conditions for 
Mur24. AdoMet was generated in situ with hMAT2A as described. [L-Met] included 0, 2, 
3.9, 7.8, 15.6, 62.5, and 125 µM. This series of kinetics was repeated with 0, 1, and 10 mM 
MTA. Obtained kinetics were converted to a Lineweaver-Burke plot for data interpretation. 
3.2.7 Kinetics of Mur24 
Reactions were prepared as previously described. For kinetics, however, a 40 min 
timepoint was used for all reaction incubations to capture the initial velocity as determined 
by a time-course assay and generation of AdoMet in situ via hMAT2A was ensured to not 
limit the reaction rate (SI Figure 3.1). Additionally, a nine-point standard curve was 
generated using commercial 2-oxobutyrate ranging from 20 nM to 10 μM. Standards and 
reactions were derivatized with MBTH. Reactions were analyzed using HR-MS. Peak area 
from extracted ion chromatograms (using both stereoisomer peaks, see SI Figure 3.5) was 
converted to [2-oxobutyrate] (nM) using the standard curve. GraphPad Prism 7 was used 
for all kinetic analysis. Additionally, kinetic assays were repeated at pH 7.0 and 9.0, as 
well as 28 and 37oC temperatures. 
3.2.8 FPLC analysis of SphL and LipJ 
Proteins were overexpressed and purified as described (Error! Reference source 
not found.). Rather than being drop frozen, however, proteins were kept on ice while FPLC 
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was prepared. An isocratic flow of Buffer C (20 mM HEPES, 250 nM NaCl, pH 8) at 0.4-
0.6 mL/min was used to maintain a pressure of no more than 3.0 mPa2 and 280 nm 
wavelength was monitored. Monomeric protein standards were used to create a standard 
curve including lysozyme, BSA, and catalase (14.4, 66.5, and 232 kDa, respectively). 
Following elution of all protein standards, protein of interest was injected, and 1.0 mL 
fractions were collected until all eluents were expelled. SDS-PAGE was used to confirm 
the collection containing the protein of interest. The native size of the protein was 
calculated using the elution time of appropriate collection and the generated standard curve. 
Calculated protein native size was divided by denatured monomeric size and rounded to 
the nearest whole number to give the number of units in complex to create the quaternary 
structure. 
3.2.9 Protein modeling of SphL and LipJ 
Protein modeling was initially processed using the Phyre2 web portal [116]. From 
these results, models with the best alignment coverage were analyzed in PyMOL to probe 
differences and similarities in the overall tertiary structure and the residues that look to be 
critical in the active site. 
3.3 Results and Discussion 
3.3.1 Tracking proton-exchanges throughout catalysis 
Typical of many gamma-replacement enzymes, we found that in the absence of the 
alkyl-acceptor substrate the enzyme performs an elimination half-reaction. ABTases 
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Mur24, SphL, and LipJ are all capable of converting AdoMet into methylthioadenosine 
(MTA) and an aminocrotonate intermediate that is spontaneously converted to 2-
oxobutyrate in the presence of water. We proposed that this encompassed all deprotonation 
events that could account for rate-limiting steps, with only an aza-Michael-like addition 
and cascade of reprotonation to follow. Since the alkyl-acceptor nucleoside intermediate is 
synthetically limited, we opted to explore the mechanism of these novel ABTases using 
the half-reactions. Additionally, Mur24 was used in all mechanistic studies, as it was found 
to be the most active homolog. 
Using AdoMet isotopologues generated in situ using hMAT2A and L-Met 
isotopologues, we found that L-Met (I) and L-Met-2-d1 (II) reactions formed a product 
mass of 264 m/z (the mass of MBTH-derivatized 2-oxobutyrate, Figure 3.2). L-Met-
3,3,4,4-d4 (III) and L-Met-2,3,3,4,4-d4-Mt-d3 (IV) gave a product mass of 267 m/z (Figure 
3.2, cont’d), suggesting that one proton at either the beta- or gamma-position is exchanged 
throughout catalysis. To determine the regiochemistry of this proton exchange, HCl-
catalyzed tautomerization was utilized following the enzymatic reaction. This led to 
enolate formation and an exchange of protons between the beta-position of 2-oxobutyrate 
and water. Subsequence product-derivatization and LCMS analysis revealed that 26% of 
2-oxobutyrate [264+3 m/z] was converted to [264+2 m/z], indicating that the enzymatic 




Figure 3.2 Mass spectra of varying L-Met isotopologues enzymatically converted to 
AdoMet via hMAT2A, subsequently converted to 2-oxobutyrate by Mur24, and lastly 
derivatized with MBTH. 
 
Performing the half-reaction in D2O led to an intriguing mass spectrum (Figure 
3.3), where species containing anywhere from 0-5 deuterium atoms was detected. The 
primary product of [264+2 m/z], in conjunction with the presence of D2O significantly 
perturbing Mur24 kinetics (see 3.3.2), suggests a possible 1,5-sigmatropic rearrangement 
that occurs when the acceptor (nucleoside-intermediate) substrate is not present. Additional 
protein modelling (SI Figure 3.11-3.12) aides in the discussion of this possibility in the 
conclusion of this chapter. 
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Figure 3.3 MS spectra of Mur24 half-reaction performed in D2O. Correcting for natural 
isotopic abundancies: 0D species, 25%; 1D species, 20%; 2D species, 27%; 3D species, 
10%; 4D species, 6%; 5D species, 9%. 
 
3.3.2 Rate constant determination and kinetic isotope effects 
Next, single-turnover kinetics were observed with respect to both AdoMet and 
Mur24. This showed that the half-reaction is 1st-order with respect to each (Figure 3.4, 
based on the log-based kinetics graphed), with an overall 2nd-order rate constant of (3.9 ± 
0.8) x 10-6 nm-1 min-1 (Figure 3.5). Michaelis-Menten kinetics revealed a similar 2nd-order 
rate constant (5.6 x 10-6 nm-1 min-1), with a Km of 3.3 ± 1 µM and a kcat of (19 ± 0.9) x 10-
3 min-1 (SI Figure 3.8). 
KIEs of various AdoMet isotopologues were measured with respect to 1st-order 
(kcat) and 2nd-order (kcat / Km) kinetics (Figure 3.6, Table 1.1). Protonation tracked via 
endpoint assays described previously only allow a snapshot of before and after catalysis; 
KIEs allow better understanding of protonation states throughout catalysis. Regarding L-
Met-2-d1, only a DL-mixture (1:1) was readily available. Since hMAT2A is only capable 
of converting the L-stereoisomer into AdoMet, any DL-Met-2-d1 concentrations were 
doubled. To ensure that DL-mixtures do not interfere with generating in situ AdoMet 
isotopologues and subsequently measuring KIEs, L-Met-3,3,4,4-d4 KIE was compared to 
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2X DL-Met-3,3,4,4-d4, wherein essentially no variation between the two was detected (SI 
Figure 3.7). KIEs were measured at 22, 28, and 37oC, as well as pH 7, 8 (optimal enzyme 
activity), and 9 (Scheme 1.1). KIEs of Cα- and Cβ-deprotonation were more significant at 
lower pH and higher temperatures with respect to 2nd-order rate constants. 1st-order KIEs 
were much tighter across the varying conditions, though pH still greatly affects 1st-order 
KIEs. KIEs were consistently higher when Cα-deprotonation was perturbed, although 
perturbation of Cβ-deprotonation also led to a lesser KIE. Based on this varying KIE data 
(Scheme 1.1), we propose that proton-abstraction from the donor substrate is rate-limiting 
at lower pH environments. As pH is increased, steps after elimination of MTA may 
contribute more to kcat instead, as kinetics of the half-reaction in D2O are greatly perturbed 
(SI Figure 3.6). This may occur through a combination of 1,5-sigmatropic and 1,5-
prototropic rearrangement (Figure 3.7). 
Subjecting the enzymatic reaction to a dilution curve of MTA reveals product 
inhibition that noncompetitively inhibits the half-reaction (SI Figure 3.10). This suggests 
that MTA is the first product released during catalysis (Figure 3.7). With this proposed 
mechanism in mind, the protonation state of the active site residues is never fully 
reestablished, meaning that further catalysis must rely on a thermodynamic equilibrium of 
proton exchange with the active site residues and water. This is likely why half-reaction 
(uni-bi ordered sequential) activity is drastically reduced compared to the full gamma-
replacement (bi-bi ordered sequential or double-displacement) activity. Reinforcing this 
notion, adding more enzyme to endpoint activity assays (24-hour reactions) shows that 
more enzyme leads to more product even when equilibrium has been obtained (SI Figure 
3.9). This suggests that during half-reaction kinetics, Mur24 is acting as a pseudo-substrate. 
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Another possible explanation of hindered activity with respect to the half-reaction is the 
need to for the L-vinylglycine-PLP intermediate to rotate from s-trans to s-cis (a less 
energetically favored orientation) as shown in Figure 3.7 in order for the half-reaction to 
go to completion. 
 
Figure 3.4 Single turnover kinetics of ABTase half-reaction (n = 2). Reactions varying 
[Mur24] (●) included 50 mM KH2PO4, pH 8; 50 mM KCl; 10 mM MgCl2; 40 µM PLP; 
500 µM AdoMet; and 240 nM, 480 nM, or 960 nM Mur24. Reactions varying [AdoMet] 
(■) included identical conditions, apart from 960 nM Mur24 and 125 nM, 250 nM, or 500 
nM AdoMet. Slopes of the linear regressions were 1.2 and 0.96, respectively. 
 
 
Figure 3.5 Calculation of rate constant with respect to both Mur24 (α) and AdoMet (β) 
using the rate equation shown. The half-reaction was determined to be essentially 1st-
order with respect to both α and β (the slope of each respective linear regression from 
Figure 3.3, indicating an overall 2nd-order reaction). The 2nd-order rate constant was 




Figure 3.6 Michaelis-Menten kinetics of Mur24 using methionine isotopologues. 
Reactions included 50 mM KH2PO4, pH 8; 50 mM KCl; 10 mM MgCl2; 40 µM PLP; 2 
mM ATP; 1 µM hMAT2A; 275 nM Mur24. [L-Met isotopologues] used to calculate 
Michaelis-Menten curve included 0 µM, 2.0 µM, 3.9 µM, 7.8 µM, 15.6 µM, 62.5 µM, 
and 125 µM. *DL-Met was used in place of pure L-Met; enantiomeric purity 
approximately 1:1; since hMAT2A only utilized L-Met, concentrations were doubled in 
reactions (i.e. 250 µM DL-mixture used to obtain 125 µM L-Met isotopologue). 
 
 
Table 3.1 Kinetic parameters and kinetic isotope effects determined with respect to five 
isotopologues. k* = kcat / Km **DL-Met was used in place of pure L-Met; enantiomeric 
purity approximately 1:1; since hMAT2A only utilized L-Met, concentrations were 
doubled in reactions (i.e. 250 µM DL-mixture used to obtain 125 µM L-Met 
isotopologue). 
 
 kcat (min-1) Km (μM) kcat/Km (k*) kcat(H)/ kcat(D) k*(H)/k*(D) 
L-Met (9.2 ± 0.5) x 10-2 3.4 ± 0.7 27 x 10-3 --- --- 
L-Met-2-d1** (5.2 ± 0.4) x 10-2 3.5 ± 1.1 15 x 10-3 1.8 1.8 
L-Met-3,3,4,4-d4 (7.9 ± 0.5) x 10-2 3.9 ± 0.9 20 x 10-3 1.2 1.3 
L-Met-2,3,3,4,4-d5 (4.8 ± 0.3) x 10-2 2.1 ± 0.6 23 x 10-3 1.9 1.2 
L-Met-3,3,4,4-d4** (7.3 ± 0.4) x 10-2 3.1 ± 0.8 23 x 10-3 1.3 1.1 
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Figure 3.7 KIE under varying pH and temperature conditions. *DL-Met was used in place 
of pure L-Met; enantiomeric purity approximately 1:1; since hMAT2A only utilized L-
Met, concentrations were doubled in reactions (i.e. 250 µM DL-mixture used to obtain 125 
µM L- Met isotopologue. 
3.4 Conclusion 
AdoMet is capable of forming an aldimine with PLP (AdoMet pKa 7.7; optimal 
enzyme activity and aldimine formation is pH 8). This, along with Mur24 and SphL not 
copurifying with PLP, leads us to propose that AdoMet and PLP may covalently form an 
aldimine before entering the enzyme active site (I) shown in Figure 3.7. Based on KIEs 
measured, we propose that at low pH the deprotonation of Cα is rate-limiting (III), though 
Cβ deprotonation is also perturbed in KIE studies (VI). Since a quinonoid state has not been 
detected in the lab, we propose that this state of PLP is short-lived in the catalysis (IV). 
Based on structural and biochemical evidence in methionine-γ-lyase and cystathionine-γ-
synthase studies, we believe the enamine is in E-configuration when MTA is eliminated 
(VII). Therefore, the 1,4-conjugated L-vinylglycine-PLP intermediate is initially in the s-
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trans configuration, which is kinetically favored for the full-reaction (path a). At higher pH 
conditions, we propose that rearrangement following MTA-elimination become rate-
limiting in the half-reaction (path b), as evidenced by D2O kinetics (SI Figure 3.6) and 
deuterium incorporation in overnight reactions (Figure 3.3). This may occur through a 1,5-
sigmatropic rearrangement if the intermediate is rotated to the thermodynamically-favored 
s-cis configuration (IX) or, alternatively, a 1,5-prototropic rearrangement whereby C4' is 
deprotonated by a protein residue and a proton is picked up at Cγ from the aqueous 
environment or an active site residue. Either rearrangement will lead to the PLP-bound 
aminocrotonate intermediate (X) that can be offloaded and spontaneously transformed into 
2-oxobutyrate in aqueous solution. 
ABTases SphL and Mur24 share several active site residues with ACC synthases, 
which they share primary and secondary sequence similarity with and are in closely 
connected clades in phylogenetic analysis [82]. Modeling based on the crystal structure of 
ACC synthase 1YNU shows that an arginine residue appears coordinate the carboxylate of 
AdoMet (R411 of SphL and Mur24; R407 of 1YNU). Another arginine appears to 
coordinate the phosphate of PLP (R242 of SphL and Mur24; R281 of 1YNU). A lysine is 
in the position appropriate for Cα deprotonation characteristic of PLP-dependent enzymes 
(K234 of SphL and Mur24; K273 of 1YNU). Based on modeling, no other key residues 
appear within a range possible to facilitate the acid-base chemistry required for the alkyl 
transfer. Since the lysine responsible for internal aldimine formation has been shown to 
participate in α-proton exchange in other enzymes [44, 49, 60, 72], we propose that K234 
may be responsible for both α- and β-proton exchanges that occur throughout the catalytic 
cycle of ABTases, well as protonation of the oxyanion of PLP as it enters the active-site 
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(III, VI, and II, respectively in Figure 3.7). Another possibility is that there is cofactor-
facilitated proton-exchanges occurring, whereby the phosphate of PLP can participate in 
catalysis. As determined by phylogenetic analysis, ABTases are in a distinct clade from 
most ACC synthases. ABTases SphL and Mur24 have a glycine in place of a glutamate in 
the active-site where substrates would bind to interact with PLP (G44, G41, and E47 for 
SphL, Mur24, and 1YNU, respectively). Additionally, SphL and Mur24 have a 
phenylalanine in place of a tyrosine. This creates a more hydrophobic pocket in a region of 
the active-site (3D modeling in SI Figure 3.12) that has an impact on protonation-states of 
PLP (Figure 3.7). SphL and Mur24 also lack an alpha helix near where active-site 
chemistry would take place (SI Figure 3.11). Lastly, ACC synthase 1YNU possesses a 
glutamate residue near the active Lys273 (circled red in Figure 3.7), whereas Mur24 has a 
valine residue; this likely means that Mur24 Lys234 is not pulled away from catalysis by 
electrostatic interactions that would typically occur in the ACC synthase. Together, these 
differences suggest how ABTases may have evolved to have distinct activity from ACC 
synthases, allowing a bisubstrate reaction to occur. Interestingly, gel-filtration data 
suggests ABTases are natively homo-tetramers (SI Figure 3.3-3.4), similar to 


























































































































































































































































































































Figure 3.8 Full catalytic cascade with multiple pathways proposed for Mur24: Since the 
enzyme does not copurify with PLP, we propose AdoMet covalently attaches to PLP 
forming the aldimine externally (I); as the AdoMet-PLP complex enters the active site, the 
oxyanion of PLP deprotonates Lys234 as it enters a partially hydrophobic pocket (II); once 
AdoMet-PLP complex is in position, Cα is deprotonated (III) and the quinonoid state of 
PLP is short-lived as C4' picks up a proton from Lys234 (IV); in the presence of the 
acceptor substrate (9), a conformational change in the active site occurs positioning the 
hydroxy-group of the pyridine away from the hydrophobic pocket and toward one of two 
arginine residues (V); this leads to the protonation of the ketimine, generating an iminium 
and oxyanion – consequently lowering the pKa of Hβ proton and allowing for the 
deprotonation of Cβ (VI); this leads to the E configuration until MTA is eliminated and the 
s-trans configuration is generated (VII); when the acceptor substrate is present (9) an aza-
Michael-like addition occurs (path a of VIII) and electron movement is reversed affording 
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10; when no acceptor substrate is present to generate the kinetically favorable product, the 
thermodynamically-favored s-cis product is formed (path b of VIII); the new orientation 
facilitates a 1,5-sigmatropic rearrangement to occur (IX) leading to the PLP-bound 
aminocrotonate (X); alternatively, a 1,5-prototropic rearrangement could occur in path b 
whereby C4' is deprotonated by a protein residue and a proton is picked up at Cγ from the 
aqueous environment or an active site residue. 
 
Though the enzyme appears to be irreversible, the full reaction product is capable 
of proton-exchange at the α- and β-positions. However, no proton-exchange occurred with 
2-oxobutyrate nor L-vinylglycine, likely because the true enzymatic product is the unstable 
aminocrotonate that readily tautomerizes to the imine and exchanges with water to form 2-
oxobutyrate in aqueous solution. 
As earlier studies suggested, ABTase substrate specificity remains strict. Using 
AdoMet with various S-nucleophiles as acceptors (e.g. L-Cys and 2-mercaptoethanol) 
demonstrated no gamma-replacement activity. This means that strengthening the 
nucleophile from the native nitrogen of the phospho-nucleoside intermediate (9) to a sulfur 
does not overcome substrate specificity alone. 
 There is a growing body of interesting PLP-dependent gamma-position chemistry. 
Most established of these is the cystathionine gamma-synthase (CGS) and lyases (CGL) 
involved in transsulfuration and reverse transsulfuration, respectively [73, 74]. CGS 
catalyzes the gamma-replacement of O-succinylhomoserine, eliminating succinate and 
replacing it with cysteine for form cystathionine [47, 75]. CGL eliminates cysteine from 
cystathionine, releasing 2-oxobutyrate and ammonium [74]. Mirroring the KIEs measured 
with the newly discovered ABTases, plant and bacterial CGSs catalyze the replacement of 
substituents at the γ-position of amino acids through a common α-proton exchange as well 
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as a rapid β-proton exchange [76]. LolC, a critical enzyme in loline alkaloid biosynthesis, 
is proposed to have similar activity to CGS, breaking a Cγ-O bond, but creating a new Cγ-
N bond rather than a new Cγ-S bond [80]. Herein, we provide further evidence that 
ABTases such as Mur24 are employing a similar mechanism to catalyze Cγ-S bond 
breaking and Cγ-N bond formation – a greater feat in regards to nucleophilicity compared 
to the CGS Cγ-O bond is breaking and Cγ-S bond formation [81, 82]. Similar to loline 
alkaloid biosynthesis, a simple methyltransferase-like SN2-type substitution looks possible 
(such as that seen in polyamine biosynthesis like spermidine [82, 84]), but the chemical 
strategy to transfer this group is much more intricate. Recently, utilization of PLP-
dependent gamma-replacement catalysis has been discovered in the formation of alkyl-
substituted pipecolate structures in citrinadin and fusaric acid biosynthesis (CndF and 
Fub7, respectively). Cγ-O bond breaking and Cγ-C bond formation of CndF and Fub7 is 
similarly uses PLP-dependent gamma-replacement catalysis, however this is done with 
somewhat more substrate flexibility than the ABTases [85, 87, 88]. Intriguingly, Fub7 
utilizes an aldehyde substrate as a nucleophile (in the tautomerized state), rather than using 
it as an electrophile [87]. Clearly, this family of enzyme activities has a lot left to be 
uncovered. Though the general mechanism appears to be similar thus far – the nucleophiles 
and electrophiles used, the substrate specificity, and the elementary rates constants 
governing rate-limiting and subsequent steps can all vary greatly. This work adds a better 




3.5 Supporting Information 
SI Table 3.1 Primers used for cloning sphL. 
Primer Sequence Note 
sphL_pET30A_FWD 5'-GGTATTGAGGGTCGCATGAGTGTGCCGCTGGATG -3' Used for SphL 
expression sphL_pET30A_REV 5'-AGAGGAGAGTTAGAGCCGTTAAGCTGCCAGGTCCGG-3' 
 
SI Table 3.2 LCMS gradient method used to detect 2-oxobutyrate-MBTH. 
 Time H2O, 0.1% formic acid 
ACN, 0.1% 
formic acid Flow 
1 0 min 95% 5% 0.4 mL/min 
2 10 min 20% 80% 0.4 mL/min 
3 16 min 20% 80% 0.4 mL/min 
4 17 min 95% 5% 0.4 mL/min 
5 22 min 95% 5% 0.4 mL/min 
 
 
SI Figure 3.1 hMAT2A coupled reaction to make AdoMet in situ does not affect the 
















































































SI Figure 3.2 MBTH-derivatized product from HCl-catalyzed tautomerization of 2-
oxobutyrate isotopologue formed from AdoMet-3,3,4,4-d4. After biocatalysis, one 
deuterium was lost to proton exchange in H2O. After HCl-catalyzed tautomerization 
(26% conversion after isotope distribution correction, assuming no β, γ-hydride shift), 
one additional deuterium was lost. This indicates that biocatalysis and HCl-catalyzed 
tautomerization each led to one proton being exchanged at the β-position throughout the 
alkyl-group modifications. (Note: L-Met isotopologue stocks used were 99% pure, 




SI Figure 3.3 SDS-PAGE gel of IMAC-purified SphL and LipJ, both His-tagged 






























SI Figure 3.4 Commercially available lysozyme, bovine serum albumin, and catalase were 
used to construct a standard curve (R2=0.9981, n = 2). The linear regression was used to 
approximate the native sizes of both SphL and LipJ (176 kDa and 210 kDa, respectively). 

















SI Figure 3.5 Following MBTH derivatization of 2-oxobutyrate, two stereoisomers are 
formed with distinct retention times (extracted ion chromatogram shown). For kinetic 


















































SI Figure 3.6 Half-reaction of Mur24 in D2O significantly lowers the kcat (kcat(H) / 
kcat(D) = 2.4), suggesting that the active site is exposed to the aqueous environment 
throughout half-reaction catalysis and steps following MTA-elimination can perturb 





















SI Figure 3.7 Michaelis-Menten kinetics comparing pure L-Met-3,3,4,4-d4 to a DL-Met-
3,3,4,4-d4 mix.  *DL-Met was used in place of pure L-Met; enantiomeric purity 
approximately 1:1; since hMAT2A only utilized L-Met, concentrations were doubled in 
reactions (i.e. 250 µM DL-mixture used to obtain 125 µM L-Met isotopologue). This 
demonstrates that a DL-Met-2-d1 mix as opposed to pure L-Met-2-d1 in kinetic studies 


























SI Figure 3.8 Michaelis-Menten kinetics comparing L-Met to L-Se-Met (no statistically 
significant difference in any kinetic parameters present, suggesting elementary step of 



















SI Figure 3.9 End-point assay of a 24-hour reaction with varying [Mur24]. This indicates 
that the enzyme is acting as a pseudo-substrate, whereby more enzyme will lead to more 


















SI Figure 3.10 Lineweaver-Burke plot of MTA product-inhibition. Considering standard 
error, the mode of inhibition looks most likely to be noncompetitive, indicative of MTA 
being the first product released during catalysis. 
 
 
SI Figure 3.11 Predicted SphL structure modelled after an ACC synthase (PDB: 1YNU) 





SI Figure 3.12 Binding pocket of SphL modelled using ACC synthase (PDB: 1YNU) 
with PLP. Most notable difference is the greater hydrophobicity in a region of SphL 




 DOWNSTREAM BIOSYNTHESIS OF SPHAERIMICIN: FORMATION OF THE 
DIHYDROXYLATED PIPERIDINE RING 
4.1 Introduction 
With the functional and mechanistic characterization of ABTases described by 
Zheng et al [82] and in Chapter 3 of this dissertation, it is now known that all ADR-GlyU-
containing highly-modified nucleosides contain a commonly derived N-alkylamine linker 
– achieved biosynthetically via PLP-dependent gamma-replacement catalysis using 
AdoMet as a cosubstrate. Clearly, from this point the biosynthetic routes vary widely in 
additional tailoring (apparent from the structures of the mature natural products). This 
chapter describes some of the preliminary bioinformatics and biochemical characterization 
of downstream biosynthesis in forming the dihydroxylated piperidine ring of sphaerimicin. 
Lastly, a proposed pathway based on this data is discussed. 
4.2 Materials and Methods 




4.2.2 Cloning, overexpression, and purification of proteins 
See 3.2.2. Mutants H117A and D119A were made using primers generated by IDT 
(SI Table 4.1). 
4.2.3 Activity assay of SphK and SphN 
Wildtype and mutant SphK assays were set up using 500 µM subsrate, 1 mM 2-
oxobutyrate, 50 µM Fe(II), and 500 nM of recombinant protein. Reactions were incubated 
overnight. Proteins were precipitated using 1:1 water:acetonitrile. Reactions were then 
analyzed on both an Agilent 6120 Quadrupole and Agilent 6230 TOF using the HILIC 
column. 
4.2.4 FPLC analysis of SphK and SphN 
See 3.2.8. 
4.3 Results and Discussion 
4.3.1 Functional assignment of SphK as a β-hydroxylase 
A putative β-hydroxylase resembling a L-proline cis-4-hydroxylase [117, 118], 
SphK, has shown activity with 1A to form 2 (Figure 4.1). This suggests that an 1A is an 
intermediate in sphaerimicin biosynthesis and that hydroxylation occurs after N-
alkylamine transfer (HPLC traces shown in Figure 4.2) catalyzed by SphL, the ABTase 
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homologue described in Chapter 3. Due to limited substrate, stereochemistry of the 
hydroxyl-incorporation was not determined. Hydroxylation likely doesn’t occur prior to 
the alkyltransfer, as SphK has no activity with AdoMet (1C). Additionally, SphK has no 
activity toward decarboxylated-1A (1B), suggesting that hydroxylation immediately 
follows alkyltransfer in the biosynthetic pathway. Based on secondary sequence alignment 
predicted by the HHpred online-tool, SphK shares several critical residues with a proline-
3-hydroxylase (Table 4.1). This includes an iron(II)-binding motif (HXDXnH) and a 2-
oxobutyrate binding-residue. Successful mutations of two of these residues shows 
significantly hindered activity in overnight-reactions (Figure 4.3). This is likely due to 
poorer coordination of the cofactor in the active-site, typical of other Fe(II)-dependent 
mutant proteins. Quaternary structural analysis using gel-filtration showed that SphK is 





























































Figure 4.2 HPLC trace of SphK activity: the sole substrate found active with SphK was 
nucleoside-intermediate 1A. 
 
Table 4.1 Binding motifs predicted in SphK based on a homologous protein (proline 3-
hydroxylase; PDBe 1E5R). 
 




P3H H107 D109 H158 R168 




























4.3.2 Functional assignment of SphN as a putative transketolase 
Based on primary and predicted-secondary sequence alignment, SphN is a classified 
as a putative transketolase. In order to test this, a real-time assay of the half-reaction was 
examined. Due to the unavailability of the acceptor (nucleoside intermediate), full catalytic 
activity was not demonstrated. Using gel-filtration, SphN quaternary structure was 
determined to be natively monomeric. 
 
Figure 4.4 Canonical mechanism of a transketolase double-displacement reaction, 
wherein a 2-carbon donor covalently binds the thiamine pyrophosphate coenzyme (I); 
this 2-carbon unit will be added to the acceptor substrate (II). In this assay, the half-
reaction measured using a real-time enzyme-coupled assay, whereby glyceraldehyde 3-
phosphate generated as the product after xylulose 5-phosphate modification; this assay 
utilized catalytically-efficient, commercially-available triosephosphate isomerase and 
glycerophosphate dehydrogenase in order to detect the oxidation of NADH using UV-vis 






Figure 4.5 Relative activity of SphN based on UV-vis-based real-time enzyme-coupled 
assay: Initial velocity of SphN compared to a commercially-available positive-control E. 




Hydroxylation of the N-alkylamine linker (product of SphL) has been demonstrated 
by the now functionally characterized SphK. We propose that this is followed by a PLP-
dependent decarboxylation (Figure 4.6), based on bioinformatics and the activity of 
homologous Mur23 (from the biosynthesis of the similar highly-modified nucleoside 
antibiotic, muraymycin). Next, we propose that an oxidative deamination of the N-
alkylamine linker via SphO. This enzyme is putatively FMN-dependent and has similarity 
to other enzymes capable of oxidative deamination. This would be an intriguing addition 
to the biosynthetic pathway, as an oxidative dephosphorylation has been characterized 
earlier in the pathway, but never an oxidative deamination. This would make a suitable 
aldehyde that could be used as a 2-carbon acceptor substrate for the putative transketolase, 
SphN. Partial activity of SphN has been demonstrated in this chapter. This would account 
for the 5-carbon scaffold (see Figure 4.6) necessary to form the piperidine ring shown in 
the mature natural product, sphaerimicin. 
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Figure 4.6 Proposed biosynthetic pathway of sphaerimicin piperidine ring formation 
based on bioinformatics and preliminary biochemical/functional protein characterization. 
 
4.5 Supporting Information 
SI Table 4.1 Primers used for cloning wildtype and mutant SphK expression, as well as 
SphN expression. 
 
Primer Sequence (single-point mutation underlined) Note 
sphK_pET30A_FWD 5'-GGTATTGAGGGTCGCATGATGAACCACGTTCGTGAAGTCAG -3' Used for 
SphK 
expression sphK_pET30A_REV 5'-AGAGGAGAGTTAGAGCCCTTATTCTGCCGCCGCCACG-3' 
sphK_H117A_FWD 5'-GGTCGCACCTGTTATTCTGTGGCTCGTGATGAAACGGCCCGCTAC-3' Used for SphK 
mutant 
expression sphK_H117A_REV 5'-GTAGCGGGCCGTTTCATCACGAGCCACAGAATAACAGGTGCGACC-3' 
sphK_D119A_FWD 5'-CTGTTATTCTGTGCATCGTGCTGAAACGGCCCGCTACCACG-3' Used for SphK 
mutant 
expression sphK_ D119A_REV 5'-CGTGGTAGCGGGCCGTTTCAGCACGATGCACAGAATAACAG-3' 
sphN_pET30A_FWD 5'-GGTATTGAGGGTCGCATGAACGCGGCGACCACC-3' Used for 
SphN 





SI Figure 4.1 SDS-PAGE gel of IMAC-purified SphK, SphO, and SphN, both His-tagged 
recombinant proteins heterologously expressed in E. coli BL21 cells. 
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